January 26, 1999
Harvard Medical School
A study by Evan Snyder, an assistant professor of neurology at Children's Hospital and Harvard Medical School, and his colleagues validates a decade's worth of research into the cell biology of brain development in mice. It also moves current attempts at harnessing neural stem cells for the treatment of human disease one step closer to reality. Conditions ranging from inherited neurogenetic defects, such as Tay-Sachs disease, to birth-related oxygen deprivation, spinal cord damage, and brain cancer could one day be treated with neural stem cells, says Snyder.
ANAHEIM, Calif.--January 25, 1999--Like many students of the human brain, Evan Snyder for years has helped finance and publish his work on mice by arguing that it might yield important insights into the human organ's development and disease. Few scientists ever get to redeem that promise.
The above story is based on materials provided by Harvard Medical School. Note: Materials may be edited for content and length.
Cite This Page:
Harvard Medical School. "Human Neural Stem Cells Advance Distant Prospect Of Reseeding Damaged Brain." ScienceDaily. ScienceDaily, 26 January 1999. <www.sciencedaily.com/releases/1999/01/990126082134.htm>.
Harvard Medical School. (1999, January 26). Human Neural Stem Cells Advance Distant Prospect Of Reseeding Damaged Brain. ScienceDaily. Retrieved March 10, 2014 from www.sciencedaily.com/releases/1999/01/990126082134.htm
Harvard Medical School. "Human Neural Stem Cells Advance Distant Prospect Of Reseeding Damaged Brain." ScienceDaily. www.sciencedaily.com/releases/1999/01/990126082134.htm (accessed March 10, 2014).